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Abstract
Context: Oxidative stress has been implicated in the pathogenesis of type 2 diabetes mellitus (T2DM) and its 
complications.
Aims: This study was conducted to determine and compare total antioxidant status (TAS), vitamin C and E levels in 
T2DM patients and healthy control subjects.
Settings and Design: Fifty-five previously diagnosed DM patients aged between 34 years and 70 years and 50 control 
subjects aged between 35 years and 69 years were consecutively recruited into this study.
Materials and Methods: Blood pressure (mmHg), body mass index (kg/m2), concentrations of plasma glucose (mmol/l), 
lipid profile (mmol/l), TAS (mmol/l), vitamins C (μmol/l), and E (μmol/l) were determined in all participants.
Statistical Analysis Used: Statistical Package for Social Sciences (SPSS) version 11.0 was used for statistical analysis.
Results: The mean plasma TAS (1.18 ± 0.27 mmol/l), vitamin C (26.59 ± 7.39 μmol/L) and vitamin E (15.33 ± 4.05 μmol/l) 
of T2DM patients were significantly lower (P=0.0001 for all) than those of controls (1.58 ± 0.28 mmol/l, 43.56 ± 6.86 μmol/l, 
31.22 ± 6.20 μmol/l respectively). TAS had a positive correlation with vitamin E (r=0.588; P=0.013) but no correlation 
with vitamin C (r=−0.387; P=0.139) among diabetics.
Conclusions: TAS, vitamin C and E levels are reduced in T2DM patients compared with those of controls.
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Introduction
Type 2 diabetes mellitus (T2DM) is characterized by 
peripheral insulin resistance, impaired insulin secretion and 
excessive hepatic glucose production.[1‑3] Oxidative stress may 
contribute to the pathogenesis of DM through impairment 
of insulin action, injury to pancreatic β‑cells, increased lipid 
peroxidation, and vascular endothelial damage.[4‑7]
Antioxidants like vitamins C and E provide a defense system 
against free radical‑induced damage.[2,8]
Earlier studies suggest that diabetics have lower plasma 
TAS, vitamin C and E concentrations than those without 
DM.[2‑4,9] This study was conducted to determine and 
compare TAS, vitamin C and E levels in T2DM patients 
and healthy controls.
Materials and Methods
The study was conducted after obtaining approval from the 
hospital’s ethical committee.
Diabetic patients were previously diagnosed T2DM 
patients on dietary and oral hypoglycemic (Metformin 
and Glibenclamide) therapy attending the Metabolic and 
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Medical Outpatient Clinics of the hospital and control 
subjects were selected from among the hospital workers. 
Fifty‑five consenting patients between 34 and 70 years and 
50 apparently healthy controls between 35 and 69 years were 
consecutively recruited into this study. Participants with 
diagnosed cardiovascular disease, kidney disease, liver disease, 
and those on vitamin C and E supplements were not included.
After obtaining informed written consent, questionnaires 
were initially administered to participants to determine 
inclusion and exclusion criteria. Wearing light clothing, the 
waist circumferences of participants were measured with a 
flexible but nonstretchable tape just above the iliac crest 
to the nearest 0.5 cm.[5] Their weights and heights were 
measured with a bathroom weighing scale (Camry) and a 
stadiometer (Surgifriend Medicals, UK) respectively.[6] Body 
mass index (BMI) was then calculated for each participant 
by dividing the weight in kilograms by the square of the 
height in meters squared (kg/m2).[7]
Blood pressure was obtained from the right upper arm after 
10 minutes of rest and with the participant in a sitting 
position, using a standard mercury sphygmomanometer 
(Accoson, UK) with appropriate cuff sizes. Systolic blood 
pressure was taken to correspond to the appearance of 
Korotkoff sounds (phase I) and diastolic blood pressure 
corresponded to the disappearance of Korotkoff sounds 
(phase V). Two consecutive measurements were taken and 
the average of the two measurements was used.[2]
After an overnight fast 10 ml of venous blood was drawn from 
participants and 3 ml was put into ethylenediaminetetraacetic 
acid (EDTA) bottles for fasting lipid analysis and 1 ml into 
fluoride oxalate bottles for fasting plasma glucose analysis. 
The remaining 6 ml was put into a lithium heparin bottle 
for analysis of vitamins C, E, and TAS.
Plasma was separated from blood cells within 30 minutes 
of collection by centrifugation at 2500 g for 15 minutes 
and transferred into plain bottles with Pasteur pipettes. 
Samples for all the assays were batch analyzed; fasting 
plasma glucose was measured within 24 hours of collection 
of blood. Samples for the lipid profile, vitamin C, vitamin E, 
and TAS analysis were stored frozen and analyzed within 
2 weeks of collection.
Plasma glucose concentration was determined using the 
glucose oxidase method (Randox kit).[10] Plasma triglyceride 
was determined using the enzymatic method of analysis 
(Randox kit).[11] Plasma total cholesterol and HDL were 
determined using the enzymatic method of analysis (Randox 
kit).[12,13] The LDL concentration was calculated from the 
total cholesterol, HDL and triglyceride concentrations 
according to the equation by Friedewald et al.[14]
Plasma vitamins C and E were determined using the 
high performance liquid chromatography (HPLC) 
method (Agilent HPLC 1100 series).[15,16] Plasma 
total antioxidant status was analyzed using the ABTS 
(2,2′‑Azino‑di‑[3‑ethylbenzthiazoline sulphonate]) 
spectrophoto‑metric method (Randox kit).[17] Randox 
quality control samples were included in every batch during 
the within‑run and between‑run analysis of samples.[17]
Statistical analysis of the data generated from the study was 
done using the Statistical Package for Social Sciences (SPSS) 
version 11.0. Values were expressed as mean±standard 
deviation. The means of continuous variables were 
compared using the unpaired Student t‑test. Correlation 
statistics were computed with Pearson coefficients. P values 
less than or equal to 0.05 were taken to be significant.
Results
Fifty‑five T2DM patients made up of 18 males and 
37 females (male to female ratio: 1:2) with a mean age of 
54.33 ± 9.09 years and 50 controls consisting of 20 males 
and 30 females (male to female ratio: 1:1.5) with a mean 
age of 53.71 ± 10.26 years were studied. There was no 
significant difference between the mean ages of patients 
and controls (P=0.745).
Patients were more obese, had higher mean blood pressure, 
higher fasting plasma glucose, and a more dyslipidemic 
lipid profile than control subjects. The mean duration of 
diabetes was 7.0 ± 3.95 years. The physical and biochemical 
parameters of patients compared with those of controls using 
student’s t‑test are summarized in Tables 1 and 2 respectively.
The mean total antioxidant status (1.18 ± 0.27 mmol/l), 
vitamin C (26.59 ± 7.39 μmol/l) and vitamin E (15.33 ± 
4.05 μmol/l) of T2DM patients were significantly lower 
(P=0.0001 for all) than those of controls (1.58 ± 0.28 mmol/l, 
43.56 ± 6.86 μmol/l, 31.22 ± 6.20 μmol/l respectively) 
[Table 3].
From the correlation statistics Table 4, TAS had a positive 
correlation with vitamin E (r=0.588; P=0.013) but no 
correlation with vitamin C (r=−0.387; P=0.139) among 
diabetics.
Discussion
Increased superoxide production, and thus increased 
oxidative stress, contributes to the pathogenesis of 
diabetes and its complications by activating four major 
molecular mechanisms and these include increased polyol 
pathway influx, increased formation of advanced glycation 
end‑products, activation of protein kinase C isoforms, 
and increased hexoseamine pathway activity.[18] These 
mechanisms exacerbate insulin resistance and may lead to 
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diabetic complications including cardiovascular disease, 
retinopathy, nephropathy, and neuropathy.
In this study, significantly lower concentrations of vitamins C 
and E and TAS were observed in diabetic patients compared 
to controls. There was a direct correlation between TAS and 
vitamin E but no correlation between TAS and vitamin C. 
Most of the evidence from previous research demonstrated 
that blood TAS, vitamins C and E concentrations in DM 
patients were significantly lower than concentrations in 
persons without DM.[2,4,19,20]
Fasting plasma glucose, total cholesterol, triglyceride, and 
low‑density lipoprotein concentrations were observed to 
be higher and high density lipoprotein concentration lower 
in diabetic patients compared to controls in this study. 
Insulin resistance and impaired insulin secretion in diabetes 
result in hyperglycemia and dyslipidemia.[2] Mitochondrial 
metabolism of the excessive glucose and free fatty acids 
results in increased superoxide production and oxidative 
stress.[18]
Antioxidants include vitamins like vitamin C (ascorbic 
acid), vitamin E (alpha‑tocopherol) and beta‑carotene, 
enzymes like catalase, superoxide dismutase, and glutathione 
peroxidase, and transition metal binding proteins like 
caeruloplasmin. In addition to albumin and urate, vitamins C 
and E have been reported to be major contributors to serum 
total antioxidant activity.[2,8,21] Vitamin E is the major 
lipid‑soluble antioxidant vitamin present in cell membranes 
and lipoproteins. Vitamin C is the most important aqueous 
phase chain breaking antioxidant.[8]
Antioxidants in combination produce a better and more 
effective action against ROS than that when working 
individually because of the synergistic interactions between 
them. Plasma total antioxidant status encompasses all the 
antioxidants in plasma including those not yet identified 
or not easily measured and is a quantitative measurement 
of the state of balance of these various components under 
specified reaction conditions. It is also a more meaningful 
estimate of plasma antioxidant capacity.[22]
It has been suggested by data from previous research that 
low levels of antioxidants may be due to their increased 
consumption during the process of combating excessive 
free radicals generated in diabetes.[2,6] As a result there is 
depletion of antioxidant reserves which include vitamins C 
and E.
Other factors that have been associated with low plasma 
antioxidant levels include low intake of antioxidant‑rich 
foods (particularly fruits and vegetables), poor health status, 
cigarette smoking, and low physical activity.[2,9] However, 
the diabetic patients in this study had been exposed to 
extensive counseling on dietary and lifestyle modification. 
This included a generous intake of fruits and vegetables to 
which most of them claimed compliance though the actual 
amount consumed could not be ascertained. All the patients 
were ambulant and clinically stable. Participants with 
significant history of cigarette smoking and current smokers 
were not included in this study. Seventy‑five percent (75%) 
of patients included businessmen and women, farmers, 
and artisans who engaged in activities that were physically 
demanding.
An inverse association has been demonstrated between 
plasma TAS and fasting plasma glucose in diabetes, 
suggesting that hyperglycemia‑induced oxidative damage 
may have contributed to low antioxidant levels.[19,20]
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Vitamin C (μmol/l) 26.59 ± 7.39 43.56 ± 6.86 0.0001*
Vitamin E (μmol/l) 15.33 ± 4.05 31.22 ± 6.20 0.0001*
Total antioxidant status (mmol/l) 1.18 ± 0.27 1.58 ± 0.28 0.0001*
*Statistically significant (P<0.05)
Table 4: Correlation between total antioxidant status 
and vitamins of patients
Vitamin N r‑value P value
Vitamin E 55 0.588 0.013*
Vitamin C 55 −0.387 0.139
r = Pearson correlation, P = Significance (two‑tailed). *Statistically 
significant (P<0.05)
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Previous research has shown that vitamins C and E 
act synergistically to reduce lipid peroxidation, inhibit 
leukocyte adhesion, enhance endothelial function (thereby 
decreasing atherogenesis), and improve insulin action.[3,7] 
They have also been found to normalize many parameters 
of oxidative stress and delay development of complications 
in diabetics.[1,6] Therefore reduced levels of vitamins C and E 
in diabetics may aggravate the degree of oxidation and 
increase susceptibility to oxidative damage and development 
of diabetic complications.[2]
It is suggested that supplementation studies be done with 
these antioxidants to see if they will improve the health 
outcome of diabetics.
In conclusion, this study showed that T2DM patients in 
Port Harcourt had significantly lower plasma levels of TAS, 
vitamins C and E compared to healthy control subjects, 
which may be as a result of oxidative stress. Increased intake 
of antioxidant‑rich foods or supplements may confer both 
cardiovascular and metabolic benefits in T2DM.
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